Skip to content

Vaginal Tumours in Sub-Saharan Africa.

Patient details
Patient details.
- Name: Ms. M - Age: 45 years - Gravida/Parity: G7P7 - Location: Rural village in Uganda
Patient case fields
Presenting Complaint

FD. presented to a local clinic with complaints of persistent vaginal bleeding, pelvic pain, and a noticeable mass in her vagina. She reported that the symptoms had been present for over six months but had worsened in the past few weeks. She also mentioned experiencing urinary incontinence and a foul-smelling vaginal discharge.

History of Present Illness

FD. is a 45-year-old woman living in a remote village in northern Nigeria. She has six children and has experienced complications during previous pregnancies, including prolonged labour and limited access to medical care. Her village has no access to modern healthcare facilities, and traditional healers are often the primary source of care.

Social History

FD.'s community has limited awareness of gynaecological health, and discussing such issues is often taboo. As a result, FD. delayed seeking help until the symptoms became unbearable. Her family is primarily dependent on subsistence farming, and her husband has discouraged seeking further medical attention due to financial constraints and cultural beliefs.

Examination Findings

On examination, a large, ulcerated mass was observed protruding from the vaginal canal. The mass was friable and bled on contact. The patient also had palpable inguinal lymph nodes, indicating possible metastasis.

Investigations

Due to the limited resources at the local clinic, a referral was made to a regional hospital where an ultrasound and biopsy were performed. The ultrasound revealed a large, irregularly shaped mass involving the vaginal wall, with possible extension to adjacent pelvic structures.

Diagnosis

Biopsy confirmed a diagnosis of squamous cell carcinoma of the vagina.

Management

Given the advanced stage of the tumour, treatment options were limited. The regional hospital lacked facilities for radiotherapy, and the nearest centre offering such treatment was over 300 kilometres away. FD. was started on palliative chemotherapy to manage symptoms and was referred to a tertiary care centre for further evaluation. However, due to the distance, cost, and cultural barriers, there was uncertainty about whether she would be able to access the recommended care.

Outcome

FD.’s condition deteriorated over the following months due to the aggressive nature of the cancer and the lack of comprehensive treatment. Her case highlights the challenges faced by women in sub-Saharan Africa, where late presentation, limited healthcare infrastructure, and socio-cultural barriers significantly impact the prognosis of gynaecological cancers.

Discussion
No data was found
Questions
1. What was the most significant delay in FD. 's case that contributed to the progression of her condition?

   (A)Delay in seeking medical attention due to cultural and social factors 

   (B) Inability to access chemotherapy

   (C) Misdiagnosis at the local clinic

   (D) Lack of pain management

2. What type of tumour was FD. diagnosed with?

    (A) Adenocarcinoma of the vagina

    (B) Squamous cell carcinoma of the vagina

    (C) Leiomyosarcoma of the vagina

    (D) Transitional cell carcinoma of the vagina

3. Which symptom was NOT reported by FD. upon her presentation to the clinic?

   (A) Persistent vaginal bleeding

   (B) Foul-smelling vaginal discharge

    (C) Difficulty swallowing

    (D) Pelvic pain

4. What was the main challenge in FD. receiving the appropriate treatment for her condition?

    (A) Lack of chemotherapy drugs

    (B) Allergic reaction to the medication

    (C) Miscommunication between healthcare providers

    (D)Distance and accessibility to radiotherapy centres 

Reveal answers

Answers

 

  1. (A) Delay in seeking medical attention due to cultural and social factors 
  2. (B) Squamous cell carcinoma of the vagina
  3. (C) Difficulty swallowing
  4. (D) Distance and accessibility to radiotherapy centres